Tag Archives: Pfizer Inc.

Johnson & Johnson Tumbles as Pfizer Set to Launch Remicade Biosimilar; Solid 3rd Quarter Doesn’t Quell Market’s Overreaction

Thriving pharmaceutical sales drove stellar quarterly results for Johnson & Johnson (New Brunswick NJ), but the company’s shares fell 3% so far this week on worries that its smash hit,… Read more »

Bristol Myers Clobbered as Cancer Drug Disappoints; Rival Merck Unanimous Winner at Medical Conference

New data are likely to prompt doctors to abandon Bristol-Myers Squibb Co.’s (New York City) immunotherapy Opdivo in favor of Merck & Co.’s (Kenilworth NJ) rival Keytruda in a large… Read more »

Glaxo Settles Bribery Charges with SEC for $20 Million; Cozy Relation of Pharma with Docs a Thing of the Past?

GlaxoSmithKline PLC (London) will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses,… Read more »

Tenet to Pay $553 Million to Settle Kickback Allegations; Culture of Corruption Dates Back Decades

Tenet Healthcare Corp. (Dallas TX) and two of its Atlanta subsidiaries have agreed to pay more than $513 million to resolve criminal and civil claims accusing the chain of paying… Read more »

Pfizer Wins Bidding War for Medivation; But Why Bother?

Pharmaceutical giant Pfizer Inc. (New York City) is paying $14 billion to buy Medivation Inc. (San Francisco), a biotech company that sells a high-priced prostate cancer medication discovered by UCLA, according to the… Read more »

U.S. Doctors, Hospitals Receive Billions from Drug, Device Makers; Report

Drug and device makers sustained their payments to doctors and teaching hospitals at nearly $6.5 billion last year, according to the figures released Thursday from a federal database. And physicians… Read more »

New Type of Non-Opioid Pain Drug Seeks FDA Approval

ELI LILLY & CO. (Indianapolis IN) said it and partner Pfizer Inc. (New York City) aim to seek approval by 2018 for a new type of pain drug that could… Read more »

Pfizer Acquires Anacor Pharma for $5.2 Billion

Pfizer Inc. (New York City) is buying Anacor Pharmaceuticals Inc. (Palo Alto CA) in a $5.2 billion deal to add an eczema gel to its portfolio, just a month after… Read more »

Pfizer Earnings Exceed Estimates; Company Raises 2016 Forecast

Pfizer Inc. (New York), which last month abandoned its $160 billion quest for Allergan PLC (Dublin IRL), reported quarterly results that blew past analysts’ estimates on sales of its new… Read more »

Pfizer Pays $785 million to Resolve a 14-year-old Lawsuit

Pfizer Inc. (New York City) agreed to pay nearly $785 million to resolve a 14-year-old lawsuit claiming its Wyeth unit overcharged the government by hiding the discounts it was giving… Read more »